Powered by Google TranslateTranslate
Original text
Rate this translation
Your feedback will be used to help improve Google Translate
Latest Press Releases
View all
TimeHeadline
22m agoCanadian Gold Resources Strengthens Board with Capital Markets Veteran Kenneth Chernin
22m agoWaraba Gold Signs Binding Agreement to Establish Joint Venture Relating to Tengrela South Exploration Permit Application in Cote d'Ivoire
22m agoSierra Madre Announces Shareholder Approval of Acquisition of Del Toro Silver Mine
22m agoFirst Quantum Minerals Reports First Quarter 2026 Results
22m agoDistrict Metals Announces $10 Million Private Placement Financing
Tscan Therapeutics Inc logo

Tscan Therapeutics Inc

About

Tscan Therapeutics Inc (NASDAQ:TCRX) — investor relations, events, news, and company updates on 6ix.

Latest News

Apr 27 2026
TScan Therapeutics Announces Upcoming Presentation at the American Society of Gene and Cell Therapy 29th Annual Meeting
Apr 8 2026
TScan Therapeutics to Participate in the 25th Annual Needham Virtual Healthcare Conference
Mar 4 2026
TScan Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
Feb 26 2026
TScan Therapeutics Completes Enrollment in Cohort C of Phase 1 ALLOHA™ Trial and Announces FDA Clearance of Investigational New Drug Applications for Heme Candidates TSC-102-A01 and TSC-102-A03
Feb 25 2026
TScan Therapeutics to Participate in the TD Cowen 46th Annual Health Care Conference

Financials

Revenue
$10.32 M
Market Cap
$57.47 M
EPS
-1.00

Community Chat

Ask AI

6ix6ixAIEvents